论文部分内容阅读
Nicotinamide phosphoribosyltransferase (NAMPT), a rate-limiting enzyme in mammalian NAD biosynthesis, has become an attractive target for drug discovery.Activating NAMPT has been shown by our lab to be a therapeutic strategy for stroke, and inhibiting NAMPT has been demonstrated by others to be a therapeutic strategy for cancer.